BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12494871)

  • 1. Flow cytometric analysis of DMBA-induced early in vivo ras expression.
    Gyöngyi Z; Grama L; Nádasi E; Sándor J; Németh A; Varga C; Kiss I; Ember I
    In Vivo; 2002; 16(5):323-6. PubMed ID: 12494871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific N-ras mutation in bone marrow within 48 H of 7,12-dimethylbenz[a]anthracene treatment in Huggins-Sugiyama rat leukemogenesis.
    Osaka M; Matsuo S; Koh T; Sugiyama T
    Mol Carcinog; 1996 Jul; 16(3):126-31. PubMed ID: 8688147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specific N-ras mutation in rat 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia.
    Osaka M; Koh T; Matsuo S; Sugiyama T
    Leukemia; 1997 Apr; 11 Suppl 3():393-5. PubMed ID: 9209402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. II. Effect of n-3 and n-6 fatty acids on mammary H-ras expression and PGE2 levels in DMBA-treated rats.
    Karmali RA; Chao CC; Basu A; Modak M
    Anticancer Res; 1989; 9(4):1169-74. PubMed ID: 2510583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a] anthracene-induced rat leukemia.
    Osaka M; Matsuo S; Koh T; Sugiyama T
    Mol Carcinog; 1997 Apr; 18(4):206-12. PubMed ID: 9142215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of E-2-(4'-methoxybenzylidene)-1-benzosuberone on the 7,12-dimethylbenz[alpha]anthracene-induced onco/suppressor gene action in vivo. I: A 24-hour experiment.
    Perjési P; Bayer Z; Ember I
    Anticancer Res; 2000; 20(1A):475-81. PubMed ID: 10769699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of p21/ras protein expression by diallyl sulfide in DMBA induced neoplastic changes in mouse skin.
    Arora A; Kalra N; Shukla Y
    Cancer Lett; 2006 Oct; 242(1):28-36. PubMed ID: 16448747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early modification of c-myc, Ha-ras and p53 expressions by chemical carcinogens (DMBA, MNU).
    Budán F; Varjas T; Nowrasteh G; Prantner I; Varga Z; Ember A; Cseh J; Gombos K; Pázsit E; Gobel G; Bauer M; Gracza T; Arany I; Perjési P; Ember I; Kiss I
    In Vivo; 2009; 23(4):591-8. PubMed ID: 19567395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of E-2-(4'-methoxybenzylidene)-1-benzosuberone on the 7,12-dimethylbenz[alpha]anthracene-induced onco/suppressor gene action in vivo II: A 48-hour experiment.
    Perjési P; Gyöngyi Z; Bayer Z
    Anticancer Res; 2000; 20(3A):1839-48. PubMed ID: 10928116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 7,12-dimethylbenz(a)anthracene on onco/suppressor gene action in vivo: a short-term experiment.
    Ember I; Kiss I; Pusztai Z
    Anticancer Res; 1998; 18(1A):445-7. PubMed ID: 9568117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in expression of onco- and suppressor genes in peripheral leukocytes--as potential biomarkers of chemical carcinogenesis.
    Gyöngyi Z; Ember I; Kiss I; Varga C
    Anticancer Res; 2001; 21(5):3377-80. PubMed ID: 11848497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation.
    Nakazawa H; Aguelon AM; Yamasaki H
    Oncogene; 1992 Nov; 7(11):2295-301. PubMed ID: 1437151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the chalcone analog E,E-bis(2-hydroxybenzylidene) acetone on the 7,12-dimethylbenz[a]anthracene-induced Ha-ras gene activity in vivo.
    Perjési P; Ember I; Bozak RE; Nádasi E; Rozmer Z; Varjas T; Hicks RJ
    In Vivo; 2006; 20(1):141-6. PubMed ID: 16433043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early modification of c-myc, Ha-ras and p53 expressions by N-methyl-N-nitrosourea.
    Budán F; Varjas T; Nowrasteh G; Varga Z; Boncz I; Cseh J; Prantner I; Antal T; Pázsit E; Gobel G; Bauer M; Gracza T; Perjési P; Ember I; Gyöngyi Z
    In Vivo; 2008; 22(6):793-7. PubMed ID: 19181008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell proliferation, micronuclei and hyperdiploidy/polyploidy in the mammary cells of DDT- and DMBA-treated pubertal rats.
    Uppala PT; Roy SK; Tousson A; Barnes S; Uppala GR; Eastmond DA
    Environ Mol Mutagen; 2005 Jul; 46(1):43-52. PubMed ID: 15880734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis.
    Muto S; Katsuki M; Horie S
    Cancer Sci; 2006 Sep; 97(9):842-7. PubMed ID: 16805855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-ras mutation in 7,12-dimethylbenz[a]anthracene (DMBA)-induced erythroleukemia in Long-Evans rats.
    Osaka M; Matsuo S; Koh T; Liang P; Kinoshita H; Maeda S; Sugiyama T
    Cancer Lett; 1995 May; 91(1):25-31. PubMed ID: 7750091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of DMBA induced genotoxicity in bone marrow by quercetin during skin carcinogenesis.
    Sengupta A; Ghosh S; Das S
    J Exp Clin Cancer Res; 2001 Mar; 20(1):131-4. PubMed ID: 11370819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.